In breast cancer, increased levels of the receptor tyrosine kinase REarranged during Transfection (RET) proto-oncogene have been observed in tumors compared to surrounding healthy tissue, and high RET expression has been associated with tamoxifen and AI resistance in ER+ breast cancers (16–18). The gene discussed is ESR1; the disease is breast carcinoma.